Current insights and molecular docking studies of HIV-1 reverse transcriptase inhibitors.
Singh AK, Kumar A, Arora S, Kumar R, Verma A, Khalilullah H, Jaremko M, Emwas AH, Kumar P.
Singh AK, et al. Among authors: kumar r, kumar a, kumar p.
Chem Biol Drug Des. 2024 Jan;103(1):e14372. doi: 10.1111/cbdd.14372. Epub 2023 Oct 10.
Chem Biol Drug Des. 2024.
PMID: 37817296
Review.